Clinical Trials

83 enrolled 13 charts

Neuroendocrine Tumors

NCT05199584 2026-03-05

A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations

CNSDermatologicEndocrineHead & NeckOther solid neoplasmSarcomaThoracic

20 enrolled

Uveal Melanoma, Glioma, Adenoma, Islet Cell, Laryngeal Diseases, Medulloblastoma, Melanoma, Mesothelioma, Neuroblastoma, Pituitary Diseases, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Osteosarcoma

NCT06235814 2026-02-05

MAPS

2 enrolled

Thyroid Cancer, Papillary

NCT02826928 2026-01-21

Diagnostic Performances of Urine and Plasma 5-hydroxyindolacetic Acid (5HIAA) Values in Patients With Small-intestine Neuroendocrine Tumors

116 enrolled

Carcinoid Tumor

NCT04505553 2026-01-21

Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer

EndocrineGastrointestinalNET

78 enrolled 14 charts

Gastro-enteropancreatic neuroendocrine tumor, Anus Neoplasms, Appendiceal Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Adenoma, Islet Cell, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms

NCT04362436 2026-01-14

ArTisaN

24 enrolled

Neuroendocrine Tumors

NCT01850888 2025-12-18

MIBG for Refractory Neuroblastoma and Pheochromocytoma

15 enrolled

CNSEndocrine

Neuroblastoma, Pheochromocytoma

NCT05745363 2025-12-16

Clinical Study of AL2846 Capsule in the Treatment of Differentiated Thyroid Cancer

33 enrolled

Differentiated Thyroid Cancer

NCT05631795 2025-12-03

ALPINIST

Phase 4 Completed

40 enrolled

Multiple Endocrine Neoplasia Type 1

NCT03217097 2025-11-21

MGMT-NET

116 enrolled

Neuroendocrine Tumors

NCT03872401 2025-11-10

VESALIUS-CV

12,301 enrolled

Coronary Disease, Multiple Endocrine Neoplasia Type 1

NCT03455075 2025-10-30

Study of Spermatogenesis Suppression With DMAU Alone or With LNG Versus Placebo Alone in Normal Men

92 enrolled

Multiple Endocrine Neoplasia Type 1

NCT03910660 2025-10-20

A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype.

EndocrineGenitourinaryNET

98 enrolled

Prostatic Neoplasms, Carcinoma, Small Cell, Neuroendocrine Tumors

NCT05307328 2025-10-08

RESCUE

26 enrolled

ACTH Syndrome, Ectopic, Cushing Syndrome, Pituitary ACTH Hypersecretion

NCT00410761 2025-09-24

An Efficacy Study Comparing ZD6474 to Placebo in Medullary Thyroid Cancer

331 enrolled 15 charts

Familial medullary thyroid carcinoma, Thyroid Neoplasms, Carcinoma, Medullary

NCT05077384 2025-09-16

Open-label Study of Surufatinib in Japanese Patients

36 enrolled

Neuroendocrine Tumors

NCT04702737 2025-09-12

DeLLpro-300

41 enrolled 19 charts

EndocrineGenitourinary

Neuroendocrine Prostate Cancer

NCT04462471 2025-09-08

Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers

8 enrolled 8 charts

Thyroid cancer, follicular, Thyroid Cancer, Papillary, Thyroid Neoplasms

NCT05017662 2025-09-04

A Long-term Safety Surveillance Study in Participants Previously Treated With 177Lu-IPN01072

20 enrolled

Neuroendocrine Tumors

NCT02820857 2025-09-03

BEVANEC

153 enrolled

Carcinoma, Neuroendocrine

NCT02973997 2025-08-29

Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC)

57 enrolled 14 charts

Thyroid cancer, Hurthle cell, Thyroid Cancer, Papillary, Adenocarcinoma, Follicular

NCT04186260 2025-08-24

A Gender and Culturally Specific Approach to Reduce NAFLD in Mexican-American Men

15 enrolled

EndocrineOther

Obesity, Weight Loss, Multiple Endocrine Neoplasia Type 1, Overweight, Non-alcoholic Fatty Liver Disease

NCT01471639 2025-08-15

Sprix

37 enrolled 7 charts

Emergencies, Multiple Endocrine Neoplasia Type 1

NCT01879657 2025-08-06

68Ga-DOTATATE PET-CT for Diagnosis of Neuroendocrine Tumors (NETs)

169 enrolled

Carcinoma, Neuroendocrine

NCT04197960 2025-08-05

Microwave Ablation and Surgical Resection for Micropapillary Thyroid Carcinoma

973 enrolled

Thyroid Cancer, Papillary

NCT04300790 2025-07-29

METALLICA

69 enrolled

BreastEndocrine

Breast Neoplasms, Hyperglycemia, Neoplasm Metastasis, Multiple Endocrine Neoplasia Type 1

NCT05773716 2025-07-24

Electroacupuncture and Pelvic Floor Muscle Training for Male Stress Urinary Incontinence

120 enrolled

Urinary Incontinence, Stress, Multiple Endocrine Neoplasia Type 1

NCT03697109 2025-07-16

GRACE

152 enrolled 28 charts

ACTH Syndrome, Ectopic, Cushing Syndrome, Diabetes Mellitus, Type 2, Hypertension, Pituitary ACTH Hypersecretion

NCT05071729 2025-07-14

A Study to Learn How Elinzanetant Moves Into, Through, and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Kidneys That do Not Work as Well as They Should Compared to Participants Whose Kidneys Work Normally

31 enrolled

Multiple Endocrine Neoplasia Type 1, Hot Flashes

NCT02611024 2025-07-09

Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors

CNSEndocrineGastrointestinalGynecologicNETOther solid neoplasmSarcomaThoracic

316 enrolled

Gastro-enteropancreatic neuroendocrine tumor, Carcinoma, Ovarian Epithelial, Glioblastoma, Mesothelioma, Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Neuroendocrine Tumors

NCT02279433 2025-06-24

A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b

EndocrineGastrointestinalNETThoracic

46 enrolled

Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Neuroendocrine Tumors

NCT05534594 2025-06-24

MIMETIC

8 enrolled

Thyroid cancer, medullary, Thyroid Neoplasms, Carcinoma, Medullary

NCT04400474 2025-06-19

CABATEN

CNSEndocrineHead & NeckNET

93 enrolled 17 charts

Adenocarcinoma, Paraganglioma, Pheochromocytoma, Neuroendocrine Tumors, Thyroid Carcinoma, Anaplastic

NCT05822817 2025-06-08

Comparison of Postoperative Recovery of Sevoflurane and Propofol After Transsphenoidal Surgery

Phase 4 Completed

252 enrolled

Pituitary Neoplasms

NCT04552769 2025-06-05

Abemaciclib in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer

9 enrolled 10 charts

Thyroid Neoplasms, Thyroid Carcinoma, Anaplastic

NCT03037385 2025-05-31

ARROW

590 enrolled 58 charts 5 FDA

EndocrineGastrointestinalHead & NeckNETThoracic

Thyroid Cancer, Papillary, Adenocarcinoma, Adenocarcinoma, Papillary, Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Colonic Diseases, Colonic Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Endocrine System Diseases, Endocrine Gland Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Glandular and Epithelial, Neoplasms, Nerve Tissue, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms, Thyroid Diseases, Thyroid Neoplasms, Colorectal Neoplasms, Neuroectodermal Tumors, Carcinoma, Medullary, Carcinoma, Neuroendocrine, Neuroendocrine Tumors, Multiple Endocrine Neoplasia Type 2a

NCT04129411 2025-05-20

Treatment of Papillary Thyroid Carcinoma With Radiofrequency Ablation

5 enrolled 7 charts

Papillary Thyroid Microcarcinoma, Thyroid Cancer, Papillary, Thyroid Neoplasms

NCT02246127 2025-05-11

SEQTOR

141 enrolled 27 charts

Neuroendocrine Tumors

NCT03289741 2025-05-09

A Study to Evaluate Patient Experience in the Therapy of Neuroendocrine Tumors Treated With Octreotide Long Acting Release Versus Lanreotide

Phase 4 Completed

51 enrolled 10 charts

Neuroendocrine Tumors

NCT00113360 2025-05-01

RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma

67 enrolled 6 charts

Carcinoma, Islet Cell, Carcinoma, Neuroendocrine

NCT06456723 2025-05-01

FETONET

56 enrolled 9 charts

Neuroendocrine Tumors

NCT04584866 2025-04-29

PosESS

54 enrolled

Pituitary Neoplasms

NCT04772469 2025-04-29

Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in Men

934 enrolled 13 charts